Constellation Healthcare Tech’s (CHT) “Corporate” Rating Reaffirmed at FinnCap
Constellation Healthcare Tech Inc (LON:CHT)‘s stock had its “corporate” rating reissued by FinnCap in a research report issued to clients and investors on Thursday. They currently have a GBX 310 ($3.87) price objective on the stock. FinnCap’s price objective suggests a potential upside of 65.78% from the company’s previous close.
Constellation Healthcare Tech (LON:CHT) opened at 187.00 on Thursday. The stock’s 50 day moving average is GBX 189.42 and its 200-day moving average is GBX 155.75. Constellation Healthcare Tech has a 12 month low of GBX 126.00 and a 12 month high of GBX 215.00. The firm’s market cap is GBX 156.76 million.
About Constellation Healthcare Tech
Constellation Healthcare Technologies, Inc is a healthcare services organization providing outsourced business services to the physician market. The Company operates through three operating segments: Revenue Cycle Management (RCM), Practice Management (PM) and Group Purchasing Organization (GPO). The RCM segment offers medical billing and collections, practice management, and other related services to hospital-based and office-based physicians, allowing them to focus on patient care in specialties, such as pathology, anesthesiology, radiology, cardiology, family practice, internal medicine, orthopedics, neurology and emergency medicine.
Receive News & Stock Ratings for Constellation Healthcare Tech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellation Healthcare Tech Inc and related stocks with our FREE daily email newsletter.